scorecardresearch
Saturday, August 9, 2025
TopicPembrolizumab

Topic: pembrolizumab

This experimental lung cancer drug outperforms blockbuster medicine Keytruda. But there’s a catch

Sumi Sukanya Dutta -
In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.

On Camera

YourTurn

Opinion

Bank nationalisation will be a blow to India’s mixed economy, lead to totalitarianism: Phiroze Shroff

Phiroze J Shroff -
If banks were to be nationalised, politicians would start interfering with bank officials and put undue pressure on them, Prof Shroff wrote in 1963.

Dharali floods a wake-up call for IMD, NDMA to buck up—the Himalayan region is vulnerable

Buying Russian oil, misreading Trump—3 points will define India’s next energy strategy

Economy

Go Swadeshi—RSS affiliate SJM calls for boycott of US firms Amazon, Walmart after Trump’s tariff hike

Neelam Pandey -
New Delhi: The day after the US imposed a 50 percent trade tariff on India, RSS affiliate Swadeshi Jagran Manch (SJM) has made an...

Defence

Secret to Pakistan aircraft losses in Op Sindoor could lie in Martin-Baker’s ejection seats records

Snehesh Alex Philip -
New Delhi: On 7 May this year, as India and Pakistan entered into what was to be an 88-hour conflict, British firm Martin-Baker, which...

National Interest

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Shekhar Gupta -
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.